Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients.
Published: August 14, 2020 at 05:06PM
from NYT Health https://ift.tt/345UAfL
Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients.
Published: August 14, 2020 at 05:06PM
from NYT Health https://ift.tt/345UAfL